Abstract
The REM parasomnia REM sleep behavior disorder (RBD) was described for the first time in 1986 and 10 years later identified as a prodromal stage of Parkinson’s disease in 1996 in the landmark publications of C. Schenck, M.W. Mahowald, and coworkers from Minnesota, USA. The subsequent rapidly evolving insights into RBD as an early stage of alpha-synucleinopathies (Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy) were the stimulus for W. Oertel from Marburg, Germany, and his collaborators to initiate and create a worldwide network of specialists working in this field. The aim of the network was to develop standardized diagnostic tools to discover the alpha-synucleinopathies at an early stage and to foster the development of therapies to prevent conversion of RBD into clinically manifest neurodegenerative diseases. After discussing the idea with the interested specialists at several international conferences, the Marburg research group organized the first RBD study group meetings in Marburg in 2007 and 2008. In 2009 the “International RBD Study Group (IRBDSG)” was officially founded at a meeting in Monte Verità, Switzerland. Since then nine further meetings have been held in different locations worldwide. The IRBDSG has produced nine peer-reviewed scientific publications and worked on standardization of diagnostic tools, classification of RBD, and a databank and on the design of protocols for disease-modifying studies. The discussions within the group have triggered many local, national, and international initiatives.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 1996;46(2):388–93.
Schenck CH, Bundlie SR, Mahowald MW. REM sleep behavior disorder (RBD): delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the minimum & maximum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep. 2003;26(Suppl):0794.M.
Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson’s disease to chromosome 4q21-q23. Science. 1996;274(5290):1197–9.
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388(6645):839–40.
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.
Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293–308.
Stiasny-Kolster K, Doerr Y, Möller JC, Hoeffken H, Behr TM, Oertel WH, Mayer G. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2005;128(Pt 1):126–37.
Schenck CH, Montplaisir JY, Frauscher B, et al. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med. 2013;14(8):795–806.
Postuma RB, Montplaisir JY, Wolfson C, et al. Environmental risk factors for REM sleep behavior disorder—a multicenter case-control study. Neurology. 2012;79(5):428–34.
Postuma RB, Arnulf I, Hogl B, et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord. 2012;27(7):913–6.
Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder with or without a coexisting neurologic disorder: clinicopathologic correlations in 171 cases. Sleep Med. 2013;14(8):754–62.
Dauvilliers Y, Postuma RB, Ferini-Strambi L, et al. Family history of idiopathic REM behavior disorder: a multicenter case-control study. Neurology. 2013;80(24):2233–5.
Frauscher B, Jennum P, Ju YE, et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology. 2014;82(12):1076–9.
Ferini-Strambi L, Oertel W, Dauvilliers Y, et al. Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. J Neurol. 2014;261(6):1112–8.
Postuma RB, Iranzo A, Hogl B, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol. 2015;77(5):830–9.
Jacobs ML, Dauvilliers Y, St Louis EK, et al. Risk factor profile in Parkinson’s disease subtype with REM sleep behavior disorder. J Parkinsons Dis. 2016;6(1):231–7.
Chahine LM, Xie SX, Simuni T, et al. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Parkinsonism Relat Disord. 2016;27:102–6.
Acknowledgment
WH Oertel is a Hertie Senior Research Professor, supported by the charitable Hertie Foundation, Frankfurt/Main, Germany.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Oertel, W., Mayer, G., Salminen, A.V., Schenck, C.H. (2019). The Foundation of the International RBD Study Group (IRBDSG). In: Schenck, C., Högl, B., Videnovic, A. (eds) Rapid-Eye-Movement Sleep Behavior Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-90152-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-90152-7_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90151-0
Online ISBN: 978-3-319-90152-7
eBook Packages: MedicineMedicine (R0)